Authors: Miknyoczki, SJ Chang, H Klein-Szanto, A Dionne, CA Ruggeri, BA

Citation: Sj. Miknyoczki et al., The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma, CLIN CANC R, 5(8), 1999, pp. 2205-2212

Authors: Riccio, A Aaltonen, LA Godwin, AK Loukola, A Percesepe, A Salovaara, R Masciullo, V Genuardi, M Paravatou-Petsotas, M Bassi, DE Ruggeri, BA Klein-Szanto, AJP Testa, JR Neri, G Bellacosa, A

Citation: A. Riccio et al., The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability, NAT GENET, 23(3), 1999, pp. 266-268

Authors: Ruggeri, BA Miknyoczki, SJ Singh, J Hudkins, RL

Citation: Ba. Ruggeri et al., Role of neurotrophin-trk interactions in oncology: The anti-tumor efficacyof potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models, CURR MED CH, 6(9), 1999, pp. 845-857

Authors: Miknyoczki, SJ Lang, D Huang, LY Klein-Szanto, AJP Dionne, CA Ruggeri, BA

Citation: Sj. Miknyoczki et al., Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma:Expression patterns and effects on in vitro invasive behavior, INT J CANC, 81(3), 1999, pp. 417-427

Authors: Berger, DH Chang, H Wood, M Huang, L Heath, CW Lehman, T Ruggeri, BA

Citation: Dh. Berger et al., Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status, CANCER, 85(2), 1999, pp. 326-332